Early Detection of Heart Damage in Children Receiving Cancer Treatment
Author Information
Author(s): Stolojanu Cristiana, Steflea Ruxandra, Micsescu-Olah Andrada Mara, Alexandra Ioana, Popoiu Anca, Doros Gabriela
Primary Institution: Victor Babes University of Medicine and Pharmacy
Hypothesis
Combining speckle tracking echocardiography with cardiac biomarkers can improve early detection of anthracycline-induced cardiotoxicity in pediatric oncology patients.
Conclusion
Using both echocardiography and cardiac biomarkers together helps identify heart damage in children undergoing cancer treatment sooner than traditional methods.
Supporting Evidence
- 28.3% of patients developed cardiotoxicity based on LVEF decrease.
- Patients had reduced GLS and SMOD EF, and increased MPI compared to controls.
- Combining GLS, SMOD EF, MPI, and cTnI levels significantly predicted cardiotoxicity.
Takeaway
Doctors can find heart problems in kids getting cancer treatment earlier by using special heart tests and blood tests together.
Methodology
A retrospective cohort study involving 99 pediatric oncology patients and 50 healthy controls, assessing cardiac function using echocardiography and biomarkers at multiple time points.
Potential Biases
Potential biases in patient selection and data collection due to the retrospective nature of the study.
Limitations
The study's retrospective design may introduce selection bias, and the findings may not be generalizable due to single-institution data collection.
Participant Demographics
Pediatric patients aged 1 to 18 years, newly diagnosed with cancer, with no pre-existing cardiac conditions.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 3.04–12.76
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website